232 related articles for article (PubMed ID: 34975145)
1. Relationships Between Obstructive Sleep Apnea and Cardiovascular Disease: A Bibliometric Analysis (2010-2021).
Wang Y; Shou X; Wu Y; Fan Z; Cui J; Zhuang R; Luo R
Med Sci Monit; 2022 Jan; 28():e933448. PubMed ID: 34975145
[TBL] [Abstract][Full Text] [Related]
2. Effect of CPAP therapy on nocturnal blood pressure fluctuations, nocturnal blood pressure, and arterial stiffness in patients with coexisting cardiovascular diseases and obstructive sleep apnea.
Picard F; Panagiotidou P; Weinig L; Steffen M; Tammen AB; Klein RM
Sleep Breath; 2021 Mar; 25(1):151-161. PubMed ID: 32297145
[TBL] [Abstract][Full Text] [Related]
3. Research trends in hypertension associated with obstructive sleep apnea: a bibliometric analysis.
Niu Y; Cai H; Zhou W; Xu H; Dong X; Zhang S; Lan J; Guo L
Sleep Breath; 2023 May; 27(2):411-419. PubMed ID: 35579792
[TBL] [Abstract][Full Text] [Related]
4. Obstructive sleep apnoea and comorbidity - an overview of the association and impact of continuous positive airway pressure therapy.
McNicholas WT
Expert Rev Respir Med; 2019 Mar; 13(3):251-261. PubMed ID: 30691323
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular morbidities of obstructive sleep apnea and the role of circulating extracellular vesicles.
Khalyfa A; Castro-Grattoni AL; Gozal D
Ther Adv Respir Dis; 2019; 13():1753466619895229. PubMed ID: 31852426
[TBL] [Abstract][Full Text] [Related]
6. Global research trends of obstructive sleep apnea from 2011 to 2020: a 10-year bibliometric analysis.
Pan L; Meng F; Zhang L; Shen H; Kong D; Wang W; Kang J
Ann Palliat Med; 2022 May; 11(5):1671-1686. PubMed ID: 35016523
[TBL] [Abstract][Full Text] [Related]
7. Obstructive Sleep Apnea, Hypertension, and Cardiovascular Risk: Epidemiology, Pathophysiology, and Management.
Salman LA; Shulman R; Cohen JB
Curr Cardiol Rep; 2020 Jan; 22(2):6. PubMed ID: 31955254
[TBL] [Abstract][Full Text] [Related]
8. Obstructive sleep apnea: a risk factor for cardiovascular disease.
Reishtein JL
J Cardiovasc Nurs; 2011; 26(2):106-16. PubMed ID: 21076317
[TBL] [Abstract][Full Text] [Related]
9. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome.
Drager LF; Togeiro SM; Polotsky VY; Lorenzi-Filho G
J Am Coll Cardiol; 2013 Aug; 62(7):569-76. PubMed ID: 23770180
[TBL] [Abstract][Full Text] [Related]
10. Vascular responses to hypoxia are not impaired in obstructive sleep apnoea patients free of overt cardiovascular disease.
Beaudin AE; Hanly PJ; Raneri JK; Sajobi TT; Anderson TJ; Poulin MJ
Exp Physiol; 2019 Apr; 104(4):580-600. PubMed ID: 30697840
[TBL] [Abstract][Full Text] [Related]
11. Obstructive sleep apnea and cardiovascular disease, a story of confounders!
Collen J; Lettieri C; Wickwire E; Holley A
Sleep Breath; 2020 Dec; 24(4):1299-1313. PubMed ID: 31919716
[TBL] [Abstract][Full Text] [Related]
12. Consequences of Obstructive Sleep Apnea: Cardiovascular Risk of Obstructive Sleep Apnea and Whether Continuous Positive Airway Pressure Reduces that Risk.
Khayat R; Pleister A
Sleep Med Clin; 2016 Sep; 11(3):273-86. PubMed ID: 27542874
[TBL] [Abstract][Full Text] [Related]
13. [Obstructive sleep apnea-related cardiovascular disease].
Schulz R; Grebe M; Eisele HJ; Mayer K; Weissmann N; Seeger W
Med Klin (Munich); 2006 Apr; 101(4):321-7. PubMed ID: 16607489
[TBL] [Abstract][Full Text] [Related]
14. Predictors of long-term adherence to continuous positive airway pressure in patients with obstructive sleep apnea and cardiovascular disease.
Van Ryswyk E; Anderson CS; Antic NA; Barbe F; Bittencourt L; Freed R; Heeley E; Liu Z; Loffler KA; Lorenzi-Filho G; Luo Y; Margalef MJM; McEvoy RD; Mediano O; Mukherjee S; Ou Q; Woodman R; Zhang X; Chai-Coetzer CL
Sleep; 2019 Oct; 42(10):. PubMed ID: 31587046
[TBL] [Abstract][Full Text] [Related]
15. Critical review: CPAP and weight management of obstructive sleep apnea cardiovascular co-morbidities.
Hudgel DW
Sleep Med Rev; 2018 Feb; 37():14-23. PubMed ID: 28117120
[TBL] [Abstract][Full Text] [Related]
16. Obstructive sleep apnea and hypertension: epidemiology, mechanisms and treatment effects.
Phillips CL; Cistulli PA
Minerva Med; 2006 Aug; 97(4):299-312. PubMed ID: 17008835
[TBL] [Abstract][Full Text] [Related]
17. Further Development of P4 Approach to Obstructive Sleep Apnea.
Pack AI
Sleep Med Clin; 2019 Sep; 14(3):379-389. PubMed ID: 31375206
[TBL] [Abstract][Full Text] [Related]
18. The effect of continuous positive airway pressure therapy on arterial stiffness and endothelial function in obstructive sleep apnea: a randomized controlled trial in patients without cardiovascular disease.
Jones A; Vennelle M; Connell M; McKillop G; Newby DE; Douglas NJ; Riha RL
Sleep Med; 2013 Dec; 14(12):1260-5. PubMed ID: 24210600
[TBL] [Abstract][Full Text] [Related]
19. A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease.
Maeder MT; Schoch OD; Rickli H
Vasc Health Risk Manag; 2016; 12():85-103. PubMed ID: 27051291
[TBL] [Abstract][Full Text] [Related]
20. Continuous positive airway pressure treatment improves cardiovascular outcomes in elderly patients with cardiovascular disease and obstructive sleep apnea.
Nishihata Y; Takata Y; Usui Y; Kato K; Yamaguchi T; Shiina K; Yamashina A
Heart Vessels; 2015 Jan; 30(1):61-9. PubMed ID: 24317681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
